Page 39 - Read Online

Page 14 of 14 Kobayashi et al. Hepatoma Res 2020;6:36 I http://dx.doi.org/10.20517/2394-5079.2020.24

portography and hepatic arteriography--radiologic-pathologic correlation. Radiology 2009;252:605-14.
11. Ueda K, Matsui O, Kawamori Y, Nakanuma Y, Kadoya M, et al. Hypervascular hepatocellular carcinoma: evaluation of hemodynamics
with dynamic CT during hepatic arteriography. Radiology 1998;206:161-6.
12. Shinmura R, Matsui O, Kadoya M, Kobayashi S, Terayama N, et al. Detection of hypervascular malignant foci in borderline lesions
of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-
enhanced MR imaging. Eur Radiol 2008;18:1918-24.
13. Matsui O, Kadoya M, Kameyama T, Yoshikawa J, Arai K, et al. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation
from hepatocellular carcinoma with MR imaging. Radiology 1989;173:123-6.
14. Kadoya M, Matsui O, Takashima T, Nonomura A. Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings.
Radiology 1992;183:819-25.
15. Shinmura R, Matsui O, Kobayashi S, Terayama N, Sanada J, et al. Cirrhotic nodules: association between MR imaging signal intensity
and intranodular blood supply. Radiology 2005;237:512-9.
16. Abu Rmilah A, Zhou W, Nelson E, Lin L, Amiot B, et al. Understanding the marvels behind liver regeneration. Wiley Interdiscip Rev
Dev Biol 2019;8:e340.
17. Kawamori Y, Matsui O, Kadoya M, Yoshikawa J, Demachi H, et al. Differentiation of hepatocellular carcinomas from hyperplastic
nodules induced in rat liver with ferrite-enhanced MR imaging. Radiology 1992;183:65-72.
18. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of
hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-12.
19. Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, et al. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR
Imaging--correlation with molecular transporters and histopathologic features. Radiology 2010;256:817-26.
20. Kitao A, Matsui O, Yoneda N, Kozaka K, Shinmura R, et al. The uptake transporter OATP8 expression decreases during multistep
hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 2011;21:2056-66.
21. Sano K, Ichikawa T, Motosugi U, Sou H, Muhi AM, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-
enhanced MR imaging. Radiology 2011;261:834-44.
22. Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, et al. Relationship between signal intensity on hepatobiliary phase of gadolinium
ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of
hepatocellular carcinoma. Eur J Radiol 2012;81:3002-9.
23. Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, et al. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic Acid-enhanced
magnetic resonance imaging findings of borderline lesions at high risk for progression to hypervascular classic hepatocellular carcinoma.
J Comput Assist Tomogr 2011;35:181-6.